Upfront metastasis-directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance

The aim of the present study was to explore the potential impact of upfront metastases-directed therapy (MDT) in terms of prolongation of castration-sensitive phase in a series of oligorecurrent castration-sensitive prostate cancer (PC) patients. The present article is a multicenter retrospective st...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Med Oncol
Auteurs principaux: Triggiani, Luca, Mazzola, Rosario, Tomasini, Davide, Bruni, Alessio, Alicino, Giulia, Matrone, Fabio, Bortolus, Roberto, Francolini, Giulio, Detti, Beatrice, Magli, Alessandro, Bonù, Marco Lorenzo, Ingrosso, Gianluca, Lancia, Andrea, Trippa, Fabio, Maranzano, Ernesto, Franzese, Ciro, Ghirardelli, Paolo, Vavassori, Vittorio, Scorsetti, Marta, Alongi, Filippo, Magrini, Stefano Maria
Format: Artigo
Langue:Inglês
Publié: Springer US 2021
Sujets:
Original Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8131275/
https://ncbi.nlm.nih.gov/pubmed/34008151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12032-021-01518-6
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires